Rationale for correction of endothyle dysfunction with Quercetin in complex treatment of non-alcoholic steatogepatitis and diabetic kidney disease in patients with type 2 diabetes mellitus
JavaScript is disabled for your browser. Some features of this site may not work without it.
Rationale for correction of endothyle dysfunction with Quercetin in complex treatment of non-alcoholic steatogepatitis and diabetic kidney disease in patients with type 2 diabetes mellitus